20 most recent filings and news items mentioning MRK. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/MRK/news?limit=20"
Pull MRK filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayU.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
View filing at SEC.gov →Merck Receives FDA Approval For Supplemental Biologics License Application For ENFLONSIA To Expand Indication To Prevention Of Respiratory Syncytial Virus Lower Respiratory Tract Disease In Children Under Two Years Of Age At Increased Risk For Severe RSV Disease; PDUFA Date Set F
View filing at SEC.gov →Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $146
View filing at SEC.gov →Merck's KEYTRUDA Plus Enfortumab Vedotin Approved In Canada For Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients
View filing at SEC.gov →Merck posted strong Q2 2026 sales growth led by oncology and a new launch, also narrowing full-year guidance excluding acquisition costs.
View filing at SEC.gov →Merck & Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate
View filing at SEC.gov →Merck & Co Lowers FY2026 Adj EPS Guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 Est; Raises FY2026 Sales Guidance from $65.800B-$67.000B to $66.300B-$67.300B vs $66.802B Est
View filing at SEC.gov →Why Merck Just Slashed Its Profit Outlook By Nearly 50%
View filing at SEC.gov →Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine For a Rapidly Spreading Ebola Outbreak
View filing at SEC.gov →Rick Scott Warns Beijing's New Drug Rules Could Threaten US Medicine Supply: 'Stop Being Dependent on Communist China'
View filing at SEC.gov →Barclays Maintains Overweight on Merck & Co, Raises Price Target to $150
View filing at SEC.gov →Merck Announces Strategy For Rapid, Broad And Sustainable Access To Its HIV-1 Prevention Pill Alimatravir In Low- And Middle-Income Countries
View filing at SEC.gov →Palisade Bio Analyst Sees Lead Drug Can Potentially Bridge Gap in Ulcerative Colitis
View filing at SEC.gov →Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plant and Equipment' in US
View filing at SEC.gov →Gilead, Merck Advance Potential Blockbuster Weekly HIV Pill
View filing at SEC.gov →Why Did This Arcus Biosciences Analyst Bump Price Forecast by 33%?
View filing at SEC.gov →Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfolio
View filing at SEC.gov →Merck Says FDA Approves LIPFENDRA Tablets 20 Mg As Adjunct To Diet And Exercise To Reduce Low-Density Lipoprotein Cholesterol In Adults With Hypercholesterolemia
View filing at SEC.gov →FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio
View filing at SEC.gov →Merck's Phase 3 KEYNOTE‑C93 Trial Evaluating KEYTRUDA Met Primary Endpoint Of Progression-Free Survival For Treatment Of Patients With Mismatch Repair Deficient Advanced Or Recurrent Endometrial Cancer
View filing at SEC.gov →